Natural History of the Neoplastic Locoregional Disease: Clinical and Pathological Patterns

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 4 SUPPL., 2003, Pages 1-4

  Cagol, P P ^a   Pasqual, E ^a   Bacchetti, S ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Neoplastic Locoregional Disease

Indexed keywords

ANTINEOPLASTIC AGENT;

BLADDER TUMOR; BRAIN TUMOR; BREAST TUMOR; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL FEATURE; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; DRUG INDICATION; HUMAN; HYPERTHERMIC THERAPY; KIDNEY TUMOR; LIVER CANCER; LIVER METASTASIS; LUNG TUMOR; MEDICAL DECISION MAKING; MELANOMA; OVARY CARCINOMA; PATHOGENESIS; PERITONEUM MESOTHELIOMA; PERITONEUM METASTASIS; PRIORITY JOURNAL; RETROPERITONEAL SARCOMA; SARCOMA; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR VASCULARIZATION;

GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS;

EID: 1842426544     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Agui T., McConkey D.J., Tanigawa N.: Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas. Anticancer Res.; 22(3): 1769-76, 2002.
2. Ackerman N.B., Lien W.M., Kondi E.S., Silverman N.A.: The blood supply in exerimental liver metastases. I The distribution of hepatic artery and portal vein to small and large tumors. Surgery; 66: 1067-1072, 1969.
3. Bengmark S., Hafstrom L.: The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer; 23: 198202, 1969.
4. Breedis C. and Young G.: The blood supply of neoplasms in the liver. Amer. J. Path.; 30: 969-977, 1954.
5. Cagol P.P., Da Pian P.P., Miotto D., Pilati P.L., Pasqual E.M., Talenti E., Lise M.: Vascularization of experimental liver metastases. 1 - blood supply and vascular patterns. J. Exp. Clin. Cancer Res.; 8 (2): 113-122, 1989.
6. Cagol P.P., Da Pian P.P., Merkel C., Pilati P.L., Pasqual E.M., Prevaldi C., Lise M.: Vascularization of experimental liver metastases. 2 - blood flow. J. Exp. Clin. Cancer Res.; 8 (3): 137-142, 1989.
7. Carmignani C.P., Sugarbaker T.A., Bromley C.M. And Sugarbake P.H.: Intraperitoneal cancer dissemiation: Mechanisms of the patterns of spread. Cancer and Metastasis Reviews.; 22: 465-472, 2003.
8. Demicheli R., Retsky M.W., Swartzendruber D.E., Bonadonna G.: Proposal for a new model of breast cancer metastatic development. Annals. Oncol.; 8: 1075-1080, 1997.
9. Finlay I.G., Meek D., Brunton F., et al.: Growth rate of hepatic metastases in colorectal carcinoma. Br. J. Surg.; 75: 641-644, 1988
10. Holmgren L., O'Reilly M.S., Folkman J.: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med., 1: 149-153, 1995.
11. Jayne D.G., Fook S., Loi C. and Seoe-Choen F.: Peritoneal carcinosis from colorectal cancer Br. J. Surg., 89, 1545-1550, 2002.
12. Norstein F. and Silen W.: Natural history of liver metastases from colorectal carcinoma. J. Gastrointest. Surg.; 1, 5: 398-407, 1997.
13. Sadeghi B., Arvieux C., Glehen O., et al.: Peritoneal carcinomatosis from non-gynecologic malignancies. Results of the EVOCAPE 1 multicentric prospective study. Cancer; 88: 358-363, 2000.
14. Shepherd N.A., Baxter K.J., Love S.B.: The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology; 112: 1096-1102, 1997.
15. Sugarbaker P.H.: Rationale for perioperative intraperitoneal chemotherapy as the surgical adjuvant for gastrointestinal malignancy. Reg. Cancer Treat.; 1: 66-79, 1988.
16. Sugarbaker P.H.: Peritonectomy procedures. Ann. Surg.; 221-29-42, 1995.
17. Sugarbaker P.H.: Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approch to pseudomixoma peritonei syndrome. E.J.S.O.; 27: 239-243, 2001.
18. Taylor I., Mullee M.A., Campbell M.J.: Prognostic index for the development of liver metastases in patients with colorectal cancer. Br. J. Surg.; 77: 499-501, 1990.
19. Verwaal V.J., Van Ruth S., De Bree E., Van Slooten G.W., Van Tinteren H., Boot H., Zoetmulder F.A.N.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J. Clin. Oncol.; 21: 3737-3743, 2003.
20. Zavadsky K.E., Lee Y.T.: Liver metastases from colorectal carcinoma: Incidence, resectability, and survival results [review]. Am. Surg., 60: 929-933, 1994.